On January 8, 2026, Collegium Pharmaceutical, Inc. issued full-year 2026 guidance, projecting US$805 million to US$825 ...
Dr Reddy's Laboratories launched a generic OTC ophthalmic solution in the US for relieving itchy eyes, approved by the FDA.